InVivo Therapeutics Holdings Corp. ($NVIV) - buy or sell? Stock discussion, ideas, forum

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company.

Industry: Health Care Equipment

Ticker	Exchange	ISIN
$NVIV	Nasdaq	US46186M4078

Recent news

Synacor, Inc. reports 33.2% revenue decline in FY2020

BSQUARE Corporation reports 20.5% revenue decline in 2020 and 11.3 pp EBITDA Margin growth from -12.5% to -1.2%

eMagin Corporation CAPEX surged on 125% and Revenue jumped on 10.1%

Viveve Medical, Inc. reports 28.2% CAPEX decline in 2020 and 16.6% Revenue decline

Canadian Solar Inc. Debt jumped on 22.2% and Revenue increased on 8.6%

SMTC Corporation Debt increased on 5.4% while EBITDA decreased on 3.8%

SharpSpring, Inc. revenue growth accelerated from 21.7% in FY2019 to 29.0% in FY2020

Interlink Electronics, Inc. reports 8.1 pp EBITDA Margin growth from -2.3% to 5.9% in 2020 in 2020 while 5.7% Revenue decline

Intellicheck, Inc. Net Income jumped on 122% and Revenue jumped on 40.1%

VirnetX Holding Corp revenue jumped on 355,942% and EBITDA Margin surged on 23,179 pp from -23,127% to 52.2%

Twit about NVIV stock

Share your investment idea or question on InVivo Therapeutics Holdings Corp. stock:

Latest twits on InVivo Therapeutics Holdings Corp. (NVIV)

No twits yet. Be the first to post!

Have a question about NVIV? Ask and other investors will be eager to help you.

Have an idea about NVIV? Share it with other investors.

InVivo Therapeutics Holdings Corp. stock price chart

About InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.